Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
Panagiotis
P
Baliakas
Laboratori de Citogenètica Molecular Servei de Patologia Hospital del Mar, Barcelona, Spain Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Program, IMIM-Hospital del Mar, Barcelona, Spain.
Anna
A
Puiggros
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Aliki
A
Xochelli
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
Lesley-Ann
LA
Sutton
AP-HP, Pitie-Salpetriere Hospital, Department of Hematology, and UPMC Univ Paris 06, UMRS 1138, France.
Florence
F
Nguyen-Khac
Department of Haematology, Royal Bournemouth Hospital, UK.
Anne
A
Gardiner
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
Karla
K
Plevova
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Eva
E
Minga
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Anastasia
A
Hadzidimitriou
Department of Haematology, Royal Bournemouth Hospital, UK.
Renata
R
Walewska
Department of Haematology, Royal Bournemouth Hospital, UK.
Helen
H
McCarthy
Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Margarita
M
Ortega
Consorcio Hospital General Universitario de Valencia, Spain.
Rosa
R
Collado
Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
Teresa
T
González
Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital GeransTrias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Isabel
I
Granada
Hospital Universitario Central de Asturias, Oviedo, Spain.
Elisa
E
Luño
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
Jana
J
Kotašková
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Theodoros
T
Moysiadis
Department of Haematology, Royal Bournemouth Hospital, UK.
Zadie
Z
Davis
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
Niki
N
Stavroyianni
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
Achilles
A
Anagnostopoulos
Cancer Sciences, Faculty of Medicine, University of Southampton, UK.
Jonathan C
JC
Strefford
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
Sarka
S
Pospisilova
AP-HP, Pitie-Salpetriere Hospital, Department of Hematology, and UPMC Univ Paris 06, UMRS 1138, France.
Frederic
F
Davi
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
Anastasia
A
Athanasiadou
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
Richard
R
Rosenquist
Department of Haematology, Royal Bournemouth Hospital, UK.
David
D
Oscier
Laboratori de Citogenètica Molecular Servei de Patologia Hospital del Mar, Barcelona, Spain Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Program, IMIM-Hospital del Mar, Barcelona, Spain.
Blanca
B
Espinet
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden Institute of Applied Biosciences, CERTH, Thessaloniki, Greece kostas.stamatopoulos@gmail.com.
Kostas
K
Stamatopoulos
D002881:Chromosomes, Human, Pair 12 / Q000235:genetics; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000378:metabolism / Q000401:mortality* / Q000628:therapy; D008297:Male; D020641:Polymorphism, Single Nucleotide; D014314:Trisomy / Q000235:genetics*
RBC; bio-engineered; cord blood; metabolic profile; native